Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.

This study has been completed.

Study NCT00636116 Information provided by Instituto Bioclon S.A. de C.V.

First Received: March 11, 2008 Last Updated: January 9, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2012
Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)